|
|||||
|
|
Factors associated with persistence of cholinesterase inhibitor treatments in the elderly |
|
| Authors: | Antoine Pariente MD PhD Marion Pinet PharmD Yola Moride PhD FISPE Yvon Merlière PhD Nicholas Moore MD PhD FRCPC FISPE Annie Fourrier‐Réglat PharmD PhD |
| Affiliation: | 1. Faculty of Pharmacy, University of Montreal, QC, Canada;2. INSERM U657, Service de Pharmacologie, Bordeaux, France;3. CHU de Bordeaux, France;4. Universite Victor Segalen, Bordeaux, France;5. Centre for Clinical Epidemiology & Community Studies, SMBD Jewish General Hospital, Montreal, Canada;6. Service des Projets Informationnels, CNAM‐TS, Paris, France |
| Abstract: | |
| Keywords: | Alzheimer's disease dementia cholinesterase inhibitors persistence risk factors pharmacoepidemiology |